溃疡性结肠炎
鞣花酸
炎症性肠病
布尼卡
结肠炎
医学
药理学
传统医学
多酚
化学
疾病
抗氧化剂
免疫学
内科学
生物化学
作者
Huimin Li,Jingya Ruan,Jiayan Huang,Dingshan Yang,Haiyang Yu,Yuzheng C. Wu,Yi Zhang,Tao Wang
标识
DOI:10.3390/ijms242417538
摘要
Ulcerative colitis, an immune-mediated inflammatory disease of the gastrointestinal tract, places a significant financial burden on patients and the healthcare system. Recently, reviews of the pomegranate and the abundant medicinal applications of its ellagitannins, as well as its pharmacological action, phytochemicals, metabolism, and pharmacokinetics, have been completed. However, summaries on their anti-ulcerative colitis effects are lacking. Numerous preclinical animal investigations and clinical human trial reports demonstrated the specific therapeutic effects of pomegranate and the effect of its ellagitannins against ulcerative colitis. According to the literature collected by Sci-finder and PubMed databases over the past 20 years, this is the first review that has compiled references regarding how the rich ellagitannins found in pomegranate have altered the ulcerative colitis. It was suggested that the various parts of pomegranates and their rich ellagitannins (especially their primary components, punicalagin, and ellagic acid) can inhibit oxidant and inflammatory processes, regulate the intestinal barrier and flora, and provide an anti-ulcerative colitis resource through dietary management.
科研通智能强力驱动
Strongly Powered by AbleSci AI